Every second of every day, a patient receives an implantable medical device featuring one of our biomaterials. Our customized solutions and expert services promote restorative healing while effectively supporting you in a sustainable manner.
Bioceramics
Coatings
Collagen
ECM Sheets
Polyester Amide
Polymer Composites
Polyethylenes
Thermoplastic Polyurethanes
At Biomedical, we offer medical grade osteoconductive, osteostimulative, and osteoinductive ceramic materials with tunable shape, porosity, and chemistry. Our bioceramics are available in a range of configurations with customizable remodeling time, handling, and delivery for a wide array of orthopedic applications.
At Biomedical, we have combined proven surface optimization technologies with technical and application development support for more than 30 years. If you are looking for a coating that is hydrophilic, hemocompatible and applied as one coating, our ComfortCoat® DAV coating will help you achieve your clinical goals.
At Biomedical, we provide you with a wide range of medical grade collagen. Whether you are looking for biomaterials, device components or finished devices. Implanted in 40+ million patients worldwide, our collagen is used in vascular, dental, orthopedic and wound management applications. With customizable architecture and mechanical properties, you can deliver a final product that is aligned with your (patients’) needs.
At Biomedical, our broad selection of extracellular matrices (ECMs) can be added to your portfolio with ease and efficiency. Regardless of your need, we can provide you with customizable thickness, strength and handling properties. On top of that, you can rely on the supply chain capabilities of a trusted global leader.
Our polymeric drug delivery solutions enable you to create sustained release patient therapies that can lower the dosing frequency for patients.
At Biomedical, we specialize in the development and processing and compounding of medical-grade polymers and biocomposites. Our polymer composites are designed to meet the complex needs of the medical industry, offering innovative solutions that deliver both performance and safety in a range of therapeutic applications. Whether resorbable or non-resorbable, our polymers and biocomposite parts are engineered to provide the optimal balance of strength and flexibility.
Biomedical’s Ulteeva Purity™ portfolio continues to evolve and expand to solve your most difficult clinical challenges. Whether you are looking to extend the life of joint implants, enable your minimally invasive procedures or a find a sustainable alternative to ePTFE, Ulteeva Purity™ can do it all!
Polyurethanes are renowned for its excellent biocompatibility and decades of successful use in implantable applications. With exceptional tensile strength and elongation properties, this flexible yet highly durable polymer is designed for a variety of medical uses. Its polymer backbone is constructed from building blocks that exhibit outstanding oxidative stability, ensuring reliable performance over time. Easily processed through hot melt extrusion or injection molding, this versatile material is ideal for load-bearing and articulating implants, long-term orthopedic applications, and lead insulation needs.
Diabetes is a chronic condition, with no known cure, that affects people from every walk of life, in every region around the globe. The direct and indirect costs of Diabetes are staggering, totaling $760 Billion globally.*
*Rodriguez-Saldana, J. (2023). The Economic Costs of Diabetes. In: The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-031-25519-9_3
Introducing TheraPEA™ Technology, our advanced biodegradable polyester amide platform. Designed for optimal performance, TheraPEA™ Technology delivers consistent near-linear release rates and exceptional processing flexibility. Whether you're seeking controlled release solutions or customizable processing options, TheraPEA™ Technology provides the ideal solution for your needs - sustainable, reliable, and versatile.
The aging population is increasingly experiencing wear on their joints. To address the rapidly growing demand in areas such as trauma and fusion, sports medicine, and joint reconstruction, improvements in available treatments and technologies are essential.
50% of men and 30% of women are estimated to develop coronary artery disease (CAD) at some point in their life.* Challenges in treating CAD include navigation, crossing tough, often calcific lesions, minimizing vessel damage, and durability of therapy.
*Mosca L, et al, Circulation 124(19) 2011.